“…In 1993, Hashimoto, Ikegami and co-workers first reported their famous complex, Rh 2 (S-PTTL) 4 [76,77], as a catalyst that manifested (along with its variants) high enantioselectivity levels in wide range of organic transformations [2,54,[78][79][80][81][82][83][84]. For example, in enantioselective [2,3]-sigmatropic rearrangement of the cyclic propargylic oxonium ylide shown in Scheme 5a, Rh 2 (S-PTTL) 4 provided the best enantioselectivity of 79% ee of the corresponding allenic bearing benzofuran-3-one product (Scheme 5a) [85].…”